BYCRF(BYCRF)
BYCRF
No analyst ratings available
No analyst price targets available for BYCRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $187.74B | $234.53B | $284.69B | $299.74B |
| Low | $185.43B | $227.10B | $278.15B | $292.85B |
| High | $192.54B | $251.18B | $299.11B | $314.92B |
| EBITDA Avg | $72.62B | $90.72B | $110.12B | $115.94B |
| Low | $71.73B | $87.85B | $107.59B | $113.28B |
| High | $74.48B | $97.16B | $115.70B | $121.82B |
| EBIT Avg | $69.14B | $86.37B | $104.84B | $110.38B |
| Low | $68.29B | $83.63B | $102.43B | $107.85B |
| High | $70.90B | $92.50B | $110.15B | $115.97B |
| Net Income Avg | $47.27B | $60.00B | $73.62B | $81.95B |
| Low | $45.85B | $58.21B | $71.42B | $79.50B |
| High | $50.38B | $63.96B | $78.47B | $87.35B |
| EPS Avg | $311.23 | $395.12 | $484.79 | $539.63 |
| Low | $301.93 | $383.31 | $470.30 | $523.51 |
| High | $331.73 | $421.14 | $516.71 | $575.16 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 7 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $42.85B | $48.09B | $54.04B |
| Low | $42.32B | $47.00B | $53.08B |
| High | $43.48B | $49.25B | $55.11B |
| EBITDA Avg | $16.58B | $18.60B | $20.90B |
| Low | $16.37B | $18.18B | $20.53B |
| High | $16.82B | $19.05B | $21.32B |
| EBIT Avg | $15.78B | $17.71B | $19.90B |
| Low | $15.58B | $17.31B | $19.55B |
| High | $16.01B | $18.14B | $20.29B |
| Net Income Avg | $9.91B | $11.52B | $16.15B |
| Low | $9.68B | $11.26B | $15.78B |
| High | $10.17B | $11.82B | $16.57B |
| EPS Avg | $65.58 | $76.22 | $106.83 |
| Low | $64.06 | $74.46 | $104.36 |
| High | $67.26 | $78.17 | $109.57 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 3 / 1 |